Back to search
FDAFDA · Food and drugs·Recall number D-0257-2025

Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50

Published March 19, 2025 · Recall initiated: February 10, 2025

Summary

FDA records drug Class II recall D-0257-2025, published March 19, 2025 and initiated February 10, 2025. Recalling firm: Nephron Sterile Compounding Center LLC; Status: Terminated; Reported quantity: 4,190 bottles; Lot: Lot # NA4008B, exp. date 03/03/2025 Lot # NA4005B & NA4005E, exp. date 02/20/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nephron Sterile Compounding Center LLC
Distributor
US Nationwide.
Lot
Lot # NA4008B, exp. date 03/03/2025 Lot # NA4005B & NA4005E, exp. date 02/20/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50 recalled?

Yes. FDA published recall D-0257-2025 on March 19, 2025. Reported hazard: Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.

What should I do if I have this product?

Voluntary: Firm initiated · Letter